Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
US Department of Justice
Daiichi Sankyo
Boehringer Ingelheim

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065313

« Back to Dashboard

NDA 065313 describes CEFOXITIN, which is a drug marketed by Acs Dobfar, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, West-ward Pharms Int, B Braun, and Samson Medcl, and is included in fourteen NDAs. It is available from seven suppliers. Additional details are available on the CEFOXITIN profile page.

The generic ingredient in CEFOXITIN is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for 065313
Applicant:Hospira Inc
Ingredient:cefoxitin sodium
Formulation / Manufacturing:see details
Pharmacology for NDA: 065313
Medical Subject Heading (MeSH) Categories for 065313
Suppliers and Packaging for NDA: 065313
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065313 ANDA Apotex Corporation 60505-0759 N 60505-0759-5
CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065313 ANDA Apotex Corporation 60505-0760 N 60505-0760-5

Profile for product number 001

Approval Date:Jan 23, 2006TE:APRLD:No

Profile for product number 002

Approval Date:Jan 23, 2006TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.